CSF3 and cervical cancer: Moreover, in the survival analysis, ME-180-G-CSF-derived cervical cancer-bearing mice showed significantly shorter survival than that ME-180-control-derived tumor-bearing mice (Fig. 4C OS: 42 vs. 60 days, p = 0.0049), which was consistent with the results from our recent report showing decreased survival in mice bearing G-CSF-expressing endometrial cancer19.